Voyager Therapeutics Inc (VYGR)
Financing Cash Flow
$6.46M
TTM · Period ending: · USD
VYGR Financing Cash Flow
Latest reported$6.46Mperiod ending
Latest reported$6.46Mperiod ending
VYGR TTM Cash from Financing ($22.12M → $6.46M)
TTM financing cash flow
High-resolution chart · PNG
VYGR financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 6,459,000 | |
| 4,066,000 | |
| 816,000 | |
| 1,254,000 | |
| 1,183,000 | |
| 1,241,000 | |
| 114,015,000 | |
| 113,901,000 | |
| 114,218,000 | |
| 115,195,000 | |
| 33,645,000 | |
| 33,461,000 | |
| 33,145,000 | |
| 32,404,000 | |
| 1,110,000 | |
| 1,061,000 | |
| 1,046,000 | |
| 596,000 | |
| 612,000 | |
| 871,000 | |
| 1,381,000 | |
| 3,157,000 | |
| 3,163,000 | |
| 2,977,000 | |
| 4,191,000 | |
| 3,127,000 | |
| 80,994,000 | |
| 81,129,000 | |
| 80,773,000 | |
| 80,821,000 | |
| 4,749,000 | |
| 62,578,000 | |
| 61,766,000 | |
| 61,147,000 | |
| 59,920,000 | |
| 2,024,000 | |
| 1,521,000 | |
| 1,112,000 | |
| 514,000 | |
| 74,056,000 | |
| 73,051,000 | |
| 132,807,000 | |
| 177,744,000 | |
| 110,340,000 | |
| 117,333,000 | |
| 63,507,000 | |
| 22,120,000 |